Hepatitis C virus (HCV) is predominantly transmitted through parenteral exposures to
infectious blood or body fluids. In 2019, approximately 58 million people worldwide were still …

Abstract Background Hepatitis C virus (HCV) elimination requires treating people who use
drugs (PWUD), yet< 10% of PWUD in the United States access HCV treatment; access is …

Importance Hepatitis C can be cured with direct-acting antivirals (DAAs), but Medicaid
programs have implemented fibrosis, sobriety, and prescriber restrictions to control costs …

It is critical to address hepatitis C virus (HCV) in carceral settings to achieve worldwide
elimination of the virus. We describe New Mexico's (NM) experience expanding HCV …

A 64-year-old woman presented to the liver clinic. She had known of her diagnosis of
chronic hepatitis C for “years” but had not been treated owing to treatment restrictions in the …

We evaluate the introduction of direct-acting antiviral (DAA) therapy for Hepatitis C (HCV) on
liver transplant allocation in the United States. We develop a model of listing and organ …

Hepatitis C virus (HCV) infection is a major public health challenge with a simple, highly
efficacious, all-oral therapy (direct-acting antivirals) that can achieve cure. Owing to the ease …

Hepatitis C is an infectious disease and major public health concern. Breakthroughs in
pharmaceuticals have the potential to cure Hepatitis C and cause large positive health …

Background: In the United States, it is estimated that there are more than 2 million cases of
Hepatitis C (HCV), with over 66,000 new cases since 2020 However, an estimated 75% of …

For decades, many Americans with hepatitis C have struggled to get into the continuum of
care. And unfortunately, some have died waiting for treatment that remains to be sometimes …